Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dual blockade of IL-6 and CTLA-4 regresses pancreatic tumors in a CD4 + T cell-dependent manner

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.07.939199Source: DataRank Database

Dual blockade of IL-6 and CTLA-4 regresses pancreatic tumors in a CD4 + T cell-dependent manner is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (25)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Christopher McQuinn,Mohammad Y. Zaidi ORCID,Hannah M. Knochelmann ORCID,Thomas A. Mace ORCID,Zhengjia Chen ORCID

Live enrichment

PubMed:23304386 OpenAlex:https://openalex.org/W4235192044

National Institutes of Health

Grant: 5P30CA138292-11

Winship Cancer Institute Cancer Center Support Grant

National Institutes of Health

Grant: 3P30CA138292-04S2

Winship Cancer Institute Cancer Center Support Grant

National Institutes of Health

Grant: 5R01CA208253-04

Enhancing immune therapy in pancreatic cancer by targeting IL-6

National Institutes of Health

Grant: 5R01CA228406-03

Targeting immune stroma interactions in pancreatic cancer

National Institutes of Health

Grant: 5R01CA228406-05

Targeting immune stroma interactions in pancreatic cancer

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2020/02/07/2020.02.07.939199.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.02.07.939199

repositoryhttps://doi.org/10.1101/2020.02.07.939199

http://dx.doi.org/10.1101/2020.02.07.939199

Fields of Study

Cancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchCAR-T cell therapy research0301 basic medicine03 medical and health sciences

Keywords

BlockadePancreatic cancerCancer researchCXCR3Immune systemCytotoxic T cellCXCL10T cellCTLA-4Immune checkpointMedicineBiologyImmunologyChemokineCancerImmunotherapyInternal medicineIn vitroChemokine receptorReceptor

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being